Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis.

Trial Profile

Effect of Zoledronic Acid in Patients With Prostate Cancer and Bone Metastasis.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Mar 2011

At a glance

  • Drugs Zoledronic acid (Primary)
  • Indications Cancer metastases; Prostate cancer
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 02 Mar 2011 Last checked against ClinicalTrials.gov record.
    • 05 Jun 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top